Research Progress of B-Cell Lymphoma/Leukemia-2 Inhibitor Combined with Azacytidine in the Targeted Therapy of Acute Myeloid Leukemia

OBJECTIVE: To investigate the efficacy and safety of azacytidine and B-cell lymphoma/leukemia-2 inhibitors in the treatment of patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). METHODS: The clinical data of 31 patients with AML/MDS who were clearly diagnosed with AML/MDS...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanyu, Huang, Dan, Liu, Lejia, Wang, Aixin, Gao, Yuan, Lin, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569197/
https://www.ncbi.nlm.nih.gov/pubmed/36254240
http://dx.doi.org/10.1155/2022/3992224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569197/
https://www.ncbi.nlm.nih.gov/pubmed/36254240
http://dx.doi.org/10.1155/2022/3992224

Ejemplares similares